Search
for
Sort by
Research 301–330 of 303
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- The Mask Mutation Identifies TMPRSS6 as an Essential Suppressor of Hepcidin Gene Expression, Required for Normal Uptake of Dietary Iron.
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Is COVID-19 Gender-sensitive?
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Cutaneous signs in COVID ‐19 patients: A review
- Androgen sensitivity gateway to COVID‐19 disease severity
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- The role of androgens in COVID-19
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Redefining hormone resistance in prostate cancer
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19